4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0000899243-20-017498
10% owner sold 255,000 shares at an average $24.72 ($6,304,373)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BRATTON DOUGLAS K 10% owner | 2020-06-19 | Sale | −82,481 | $24.20 | $1,995,653 | 870,554 | I |
| BRATTON DOUGLAS K 10% owner | 2020-06-19 | Sale | −62,439 | $25.00 | $1,560,850 | 808,115 | I |
| BRATTON DOUGLAS K 10% owner | 2020-06-22 | Sale | −65,373 | $24.66 | $1,611,941 | 742,742 | I |
| BRATTON DOUGLAS K 10% owner | 2020-06-22 | Sale | −24,683 | $25.12 | $619,960 | 718,059 | I |
| BRATTON DOUGLAS K 10% owner | 2020-06-23 | Sale | −16,777 | $25.69 | $430,941 | 701,282 | I |
| BRATTON DOUGLAS K 10% owner | 2020-06-23 | Sale | −3,247 | $26.19 | $85,028 | 698,035 | I |
| Open-market sales · 255,000 sh · avg $24.72 · $6,304,373 | |||||||
Loading xslF345X03/doc4.xml…